DanielAaronRobertsMD

PubMed

• Design and Implementation of an Opt-Out, End-to-End, PreemptiveTesting Program for Patients Planned for a Systemic Fluoropyrimidine.
  Garrett Rompelman, Angela Chen, Samantha Morrison-Ma, Lindsay Murray, Maria Ferzoco, Joseph O Jacobson, Craig Bunnell, Andrew J Wagner, Daniel Roberts, Jennifer Chan, ...> ;JCO Oncology Practice. 2024 Apr 12
• Defining the Educational Needs for a Community-Based Hematology/Oncology Career: A National Needs Assessment.
  Agrawal, S., Dodge, L., Pegher, J., Coleman, R., Waterhouse, D., Patell, R., Roberts, D., Rangachari, D.> ;JCO Oncology Practice. 2024 Feb 8
• Training Hematologists/Oncologists for the Academic-Community Hybrid: Creating a Fellowship Framework for the Future.
  Daniel A Roberts, Jennifer Faig, Kelly Bodio-Downey, Jason Shpilsky, Kathleen Leahy, Jonathan Wischhusen, Sara Giordano, Utkarsh Acharya, Reed Drews, David Dougherty, ...> ;JCO Oncology Practice. 2023 Jun 1
• 3 citations
  Implementing Electronic Patient-Reported Outcomes for Patients With New Oral Chemotherapy Prescriptions at an Academic Site and a Community Site.
  Jim Doolin, Jonathan L Berry, Natalia Forbath, N. Tocci, Tenzin Dechen, Stephanie Li, Rebekah A Hartwell, Jennifer K Espiritu, Daniel A Roberts, Jessica A. Zerillo, Me...> ;JCO Clinical Cancer Informatics. 2021 Jun 7
• Join now to see all

Journal Articles

• Contract research organizations in oncology clinical research: Challenges and opportunities  
  Roberts DA, Kantarjian HM, Steensma DP, Cancer, 1/1/2016
• Rasburicase-induced methemoglobinemia in two African-American female patients: an under-recognized and continued problem  
  Roberts DA, Freed JA, Eur J Haematol, 1/1/2015
• Low efficacy and high mortality associated with clofarabine treatment of relapsed/refractory acute myeloid leukemia and myelodysplastic syndromes  
  Roberts DA, Wadleigh M, McDonnell AM, DeAngelo DJ, Stone RM, Steensma DP, Leuk Res, 1/1/2015
• Outlook and Management of Patients with Myelodysplastic Syndromes Failed By Hypomethylating Agents  
  Roberts DA, Steensma DP, Curr Hematol Malig Rep, 1/1/2015
• Join now to see all

Abstracts/Posters

• Outcomes and patient�s perspectives on an oral chemotherapy education and electronic monitoring program
  Tocci NX, Doolin J, Roberts DA, Ciobotti C, Hartwell R, Espiritu J, Devlin SM, Dowling H, Trillo K, Yenulevich M, Zerillo J, Shea M, American Society of Clinical Oncology Annual Meeting, 1/15/2019
• Impact of pharmacist-led oral antineoplastic patient education on compliance with Quality Oncology Practice Initiative (QOPI) measures
  Hartwell R, Cibotti C, Roberts D, Doolin J, Yenulovich M, Trillo K, Smith M, Dowling H, Tocci N, Devlin S, Shea M, Zerillo J, Hematology Oncology Pharmacist Association Annual Meeting, 1/1/2019
• Oral chemotherapy education sessions at an academic and community cancer center
  Roberts DA, Doolin J, Cibotti C, Hartwell BA, Yenulevich M, Trillo K, Hamdan A, Rodrigues C, Smith MB, Devlin S, Dowling H, Tocci NX, Devlin SM, Shea M, Zerillo JA, J Clin Oncol, 1/1/2018
• Electronic Monitoring of patient-reported adherence and symptoms on oral chemotherapy at an academic and a community site
  Doolin J, Roberts DA, Cibotti C, Devlin S, Dowling H, Seery V, Tocci NX, Trillo K, Wright D, Yenulevich M, Zerillo JA, Shea M, J Clin Oncol, 1/1/2018
• Pulmonary Langerhans Cell Histiocytosis With Extrapulmonary Involvement: Regression and Resurgence of Lesions With Stopping and Resuming Cigarette Smoking
  Malvar, G, Roberts DA, Hamdan A, Pihan GA, College of American Pathologists Annual Meeting, Archives of Pathology & Laboratory Medicine, 1/1/2017
• Evaluating clinical tolerance and long-term outcomes of the FOLFOX6 chemotherapy regimen to treat advanced stage colorectal cancer
  Petras K, Roberts DA, Micetich K, Loyola University of Chicago Stritch School of Medicine, St. Alberts Day Research, 1/23/2013
• Join now to see all

Lectures

• Biochemical Recurrence, The ARAMIS Trial, and the non-metastatic Castrate Resistant Prostate Cancer Population 
  1/1/2019
• Impact of pharmacist-led oral antineoplastic patient education on compliance with Quality Oncology Practice Initiative (QOPI) measures 
  1/1/2019
• EPOCH vs. CHOP therapy for DLBCL: Where are we? 
  1/1/2018
• The Role of Cytoreductive Nephrectomy In metastatic RCC and the CARMENA Trial 
  1/1/2018
• Introduction to Value-Based Health Care Delivery 
  1/1/2018
• Being COMFORTable with Myelofibrosis 
  1/1/2017
• Oral Chemotherapy: Pearls and Pitfalls 
  1/1/2017
• Morbidity, Mortality and Improvement 
  1/1/2017
• Waldenstrom�s Macroglobulinemia 
  1/1/2016
• Myelodysplastic Syndrome in 30 minutes 
  1/1/2016
• Dying: The New Chronic Disease 
  1/1/2015
• Join now to see all